Criteria Fulfill
Item
patients must meet all of the following inclusion criteria at screening to be eligible for participation in this study.
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Hepatitis B, Chronic | Hepatitis B surface antigen positive | Anti-HBc IgM antibody negative | Anti-HBc IgG antibody positive
Item
1. chronic hbv infection, defined as positive serum hbsag for at least 6 months, or hbsag positive > 3 months and negative for igm anti-hbc and positive for igg anti-hbc
boolean
C0524909 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C4049511 (UMLS CUI [3])
C1096145 (UMLS CUI [4])
Age
Item
2. age < 40 years old
boolean
C0001779 (UMLS CUI [1])
Hepatitis B e antigen positive
Item
3. hbeag positive
boolean
C0392390 (UMLS CUI [1])
Hepatitis B DNA Measurement Real-Time Polymerase Chain Reaction
Item
4. hbv dna ≥ 10^7 copies/ml by abbott real-time pcr
boolean
C3641250 (UMLS CUI [1,1])
C1709846 (UMLS CUI [1,2])
Alanine aminotransferase measurement
Item
5. alt ≤ 1 uln
boolean
C0201836 (UMLS CUI [1])
Informed Consent
Item
6. willing and able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Childbearing Potential Serum hCG Negative
Item
7. negative serum β-hcg (for females of childbearing potential only)
boolean
C3831118 (UMLS CUI [1,1])
C2208823 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
Estimation of creatinine clearance by Cockcroft-Gault formula | Gender
Item
8. calculated creatinine clearance ≥ 70 ml/min by the following formula: (140 - age in years) x (body weight [kg]) / (72) x (serum creatinine [mg/dl]) [note: multiply estimated rate by 0.85 for women]
boolean
C2711451 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Hemoglobin measurement
Item
9. hemoglobin ≥ 10 g/dl
boolean
C0518015 (UMLS CUI [1])
Neutrophil count
Item
10. neutrophils ≥ 1,500 /mm^3
boolean
C0200633 (UMLS CUI [1])
Absence Therapeutic procedure Oral HBV | Absence Nucleotides | Absence Nucleosides | Absence Investigational New Drugs Hepatitis B
Item
11. no prior oral hbv therapy (e.g., nucleotide and/or nucleoside therapy or other investigational agents for hbv infection)
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,3])
C0019163 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0028630 (UMLS CUI [2,2])
C0332197 (UMLS CUI [3,1])
C0028621 (UMLS CUI [3,2])
C0332197 (UMLS CUI [4,1])
C0013230 (UMLS CUI [4,2])
C0019163 (UMLS CUI [4,3])
Protocol Compliance
Item
12. is willing and able to comply with the study drug regimen and all other study procedures and requirements
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
13. is willing and able to provide written informed consent before any study assessment is perform.
boolean
C0021430 (UMLS CUI [1])
Criteria Fulfill
Item
patients will be excluded from the study for any of the criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Liver disease Decompensated | Serum direct (conjugated) bilirubin test | Prothrombin time increased | Platelet Count measurement | Serum albumin measurement | Hepatic decompensation | Ascites | Jaundice | Encephalopathy | Bleeding varices
Item
1. decompensated liver disease defined as direct (conjugated) bilirubin > 1.2 × uln, pt > 1.2 × uln, platelets < 150,000/mm3, serum albumin < 3.5 g/dl, or prior history of clinical hepatic decompensation (e.g. ascites, jaundice, encephalopathy, variceal hemorrhage).
boolean
C0023895 (UMLS CUI [1,1])
C0205434 (UMLS CUI [1,2])
C1278038 (UMLS CUI [2])
C0151872 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0523465 (UMLS CUI [5])
C1394798 (UMLS CUI [6])
C0003962 (UMLS CUI [7])
C2010848 (UMLS CUI [8])
C0085584 (UMLS CUI [9])
C0333106 (UMLS CUI [10])
Interferon | Pegylated interferon alfa
Item
2. received interferon (pegylated or not) therapy within 6 months of the screening visit
boolean
C3652465 (UMLS CUI [1])
C0907160 (UMLS CUI [2])
Alpha-fetoprotein measurement
Item
3. α-fetoprotein > 50 ng/ml
boolean
C0201539 (UMLS CUI [1])
Liver carcinoma
Item
4. evidence of hepatocellular carcinoma (hcc)
boolean
C2239176 (UMLS CUI [1])
HCV coinfection Serology | HIV coinfection Serology | HDV Coinfection Serology
Item
5. co-infection with hcv (by serology), hiv, or hdv.
boolean
C1698259 (UMLS CUI [1,1])
C0036743 (UMLS CUI [1,2])
C4062778 (UMLS CUI [2,1])
C0036743 (UMLS CUI [2,2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C0036743 (UMLS CUI [3,3])
Kidney Diseases | Cardiovascular Diseases | Lung diseases | Nervous system disorder
Item
6. significant renal, cardiovascular, pulmonary, or neurological disease.
boolean
C0022658 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0027765 (UMLS CUI [4])
Solid organ transplant | Bone Marrow Transplantation
Item
7. received solid organ or bone marrow transplantation.
boolean
C0730400 (UMLS CUI [1])
C0005961 (UMLS CUI [2])
Immunomodulators | Adrenal Cortex Hormones | Investigational New Drugs | Pharmaceutical Preparations Nephrotoxic | Pharmaceutical Preparations Changing Renal Excretion
Item
8. is currently receiving therapy with immunomodulators (e.g., corticosteroids, etc.), investigational agents, nephrotoxic agents, or agents susceptible of modifying renal excretion.
boolean
C1527392 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C1514118 (UMLS CUI [4,2])
C0013227 (UMLS CUI [5,1])
C0392747 (UMLS CUI [5,2])
C1373187 (UMLS CUI [5,3])
Proximal tubulopathy
Item
9. has proximal tubulopathy.
boolean
C1839603 (UMLS CUI [1])
Investigational New Drugs
Item
10. use of other investigational drugs at the time of enrollment, or within 30 days
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs Class Similar
Item
11. history of hypersensitivity to any of the study drugs or to drugs of similar chemical classes
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0456387 (UMLS CUI [2,3])
C2348205 (UMLS CUI [2,4])
Pregnancy | Breast Feeding | Childbearing Potential Serum pregnancy test (B-HCG) Negative
Item
12. is pregnant or breastfeeding. women of childbearing potential must have a negative serum β - hcg during screening.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0430060 (UMLS CUI [3,2])
C1513916 (UMLS CUI [3,3])
Childbearing Potential | Gender Exclusion Coitus Partner | Gender Partner Vasectomy | Gender Partner Male sterilization | Exception Postmenopausal state | Amenorrhea Spontaneous Duration | Serum follicle stimulating hormone measurement | Bilateral oophorectomy | Hysterectomy | Contraceptive methods | Female Sterilization | Bilateral tubal ligation | Vasectomy | Hormonal contraception | Contraceptive implant | Contraceptive Patch | Contraceptives, Oral | Barrier Contraception Double | IUD | Condoms, Male | Female Condoms | Vaginal Spermicides | Vaginal contraceptive diaphragm | Contraceptive Sponge | CERVICAL CAP FOR CONTRACEPTIVE USE
Item
13. is a women of child-bearing potential (wocbp), defined as all women physiologically capable of becoming pregnant, including women whose career, lifestyle, or sexual orientation precludes intercourse with a male partner and women whose partners have been sterilized by vasectomy or other means, unless they meet the following definition of post-menopausal: 12 months of natural (spontaneous) amenorrhea or 6 months of spontaneous amenorrhea with serum fsh levels >40 miu/m or 6 weeks post surgical bilateral oophorectomy with or without hysterectomy or are using one or more of the following acceptable methods of contraception: surgical sterilization (e.g., bilateral tubal ligation, vasectomy), hormonal contraception (implantable, patch, oral), and double-barrier methods (any double combination of: iud, male or female condom with spermicidal gel, diaphragm, sponge, cervical cap).
boolean
C3831118 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0009253 (UMLS CUI [2,3])
C0682323 (UMLS CUI [2,4])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C0042387 (UMLS CUI [3,3])
C0079399 (UMLS CUI [4,1])
C0682323 (UMLS CUI [4,2])
C0024559 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
C0002453 (UMLS CUI [6,1])
C0205359 (UMLS CUI [6,2])
C0449238 (UMLS CUI [6,3])
C0455276 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0020699 (UMLS CUI [9])
C0700589 (UMLS CUI [10])
C0015787 (UMLS CUI [11])
C0589114 (UMLS CUI [12])
C0042387 (UMLS CUI [13])
C2985296 (UMLS CUI [14])
C1657106 (UMLS CUI [15])
C2985284 (UMLS CUI [16])
C0009905 (UMLS CUI [17])
C0004764 (UMLS CUI [18,1])
C0205173 (UMLS CUI [18,2])
C0021900 (UMLS CUI [19])
C0009653 (UMLS CUI [20])
C0221829 (UMLS CUI [21])
C0087145 (UMLS CUI [22])
C0042241 (UMLS CUI [23])
C0183461 (UMLS CUI [24])
C0493327 (UMLS CUI [25])
Comorbidity Excludes Protocol Compliance | Social situation Excludes Protocol Compliance | Comorbidity Interferes with Research results | Social situation Interferes with Research results
Item
14. patient has any other concurrent medical or social condition likely to preclude compliance with the schedule of evaluations in the protocol, or likely to confound the efficacy or safety observations of the study.
boolean
C0009488 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0748872 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C0748872 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Substance Use Disorders | Illicit Drugs abuse
Item
15. patient is currently abusing alcohol or illicit drugs, or has a history of alcohol abuse or illicit substance abuse within the preceding two years. please refer to appendix 3.
boolean
C0038586 (UMLS CUI [1])
C0086190 (UMLS CUI [2,1])
C0013146 (UMLS CUI [2,2])
Medical condition Acyclovir Patient need for | Medical condition Famciclovir Patient need for | Acyclovir Systemic Prolonged | Acyclovir Systemic Frequent | Famciclovir Systemic Prolonged | Famciclovir Systemic Frequent
Item
16. patient has a medical condition that requires prolonged or frequent use of systemic acyclovir or famciclovir. please refer to appendix 1.
boolean
C3843040 (UMLS CUI [1,1])
C0001367 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0209227 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
C0001367 (UMLS CUI [3,1])
C0205373 (UMLS CUI [3,2])
C0439590 (UMLS CUI [3,3])
C0001367 (UMLS CUI [4,1])
C0205373 (UMLS CUI [4,2])
C0332183 (UMLS CUI [4,3])
C0209227 (UMLS CUI [5,1])
C0205373 (UMLS CUI [5,2])
C0439590 (UMLS CUI [5,3])
C0209227 (UMLS CUI [6,1])
C0205373 (UMLS CUI [6,2])
C0332183 (UMLS CUI [6,3])